Healthcare IT security firm Imprivata has acquired the identity and access management business of Caradigm. The financial terms of the acquisition were not disclosed. Caradigm provides a range of identity and access management solutions, including governance, risk management and compliance and clinical and IT efficiency solutions such as single sign-on and multi-factor authentication to over 100 healthcare organizations globally. The acquisition will help reinforce authentication and access management platform for the healthcare enterprise to accelerate the development of new capabilities
Imprivata will be demonstrating its latest solutions for authentication, access management and patient identification at Arab Health next week in Dubai. Imprivata PatientSecure, a patient identity solution that uses palm vein biometrics, will be on show together with Imprivata OneSign, the single sign-on (SSO) and access management platform, and Imprivata Confirm ID, a solution for authentication of clinical transactions and medical devices. Imprivata PatientSecure creates a direct match between patients and their medical records across different clinical systems using palm
Imprivata released a new study entitled ‘2016 National Patient Misidentification Report‘, which reveals that patient misidentification has become rampant and carries significant consequences that negatively impact patient care and the hospital’s financial performance. The report is based on a survey of 503 top-level healthcare executives and care providers across the U.S. Among the key findings, 64 percent of respondents said that a patient is misidentified in the typical healthcare facility very frequently or all the time. The patient misidentification crisis
Imprivata is showcasing its comprehensive identity and authentication platform, Imprivata Confirm ID, and its full suite of solutions for enabling healthcare providers to access, communicate and transact patient health information securely and conveniently at the Cerner Health Conference this week in Kansas City, Missouri. Imprivata Confirm ID enables fast, secure authentication for electronic prescribing of controlled substances (EPCS), clinical workflows and remote access by allowing providers to meet DEA and state-level requirements for EPCS while ensuring a fast, efficient workflow.
In an effort to reduce paperwork, improve accuracy, and prevent identity theft, Metroplex Health System in Killeen, Texas is now using Imprivata PatientSecure, a patient identification solution that creates a direct match between individual patients and their unique medical records across different clinical systems using palm vein biometric information. “Using biometric identification helps us ensure the privacy of our patients,” commented Carlyle Walton, president and CEO of Metroplex Health System. “It also improves convenience and enhances record accuracy by preventing
In an effort to improve patient safety and eliminate duplicate patient medical records, Adventist Health System (AHS), one of the largest faith-based healthcare systems in the United States, has deployed Imprivata PatientSecure, a biometric palm-scanning technology that can identify patients at registration and immediately launch their electronic medical record. Imprivata PatientSecure is now live in 29 Adventist Health System facilities that combined serve more than 2.5 million patients annually, and will soon be deployed across almost all of the system.
In an effort to enhance patient safety by improving accuracy and helping prevent identity theft, Park Ridge Health in Western North Carolina has implemented the PatientSecure biometric identification solution. PatientSecure uses palm vein recognition biometrics to accurately identify patients at any point of entry to care at Park Ridge Health. The PatientSecure device uses infrared light to scan the palm, then links the unique biometric trait to each patient’s electronic health record. “PatientSecure provides a safe, secure, confidential and easy
Brooklyn, N.Y.-based NYU Lutheran has recently launched a new electronic health record (EHR) platform as well as Imprivata’s PatientSecure, a biometric palm-scanning technology that can identify patients at registration. The platform integrates with the health system’s 22 inpatient and outpatient care centers including NYU Lutheran Medical Center, NYU Lutheran Family Health Centers and affiliated faculty group practice offices in the NYU Langone Health System. Officials say the goal is better patient-provider communication, improved access to medical records and for patients
Imprivata has released Imprivata Confirm ID, a new solution that expands and complements the capabilities of its single sign-on and authentication platform, Imprivata OneSign. Using Imprivata Confirm ID, healthcare workers are able to quickly and securely authenticate the use of medical devices and clinical workflows. This significantly improves security and compliance without compromising efficiency or affecting patient care. When used in concert with Imprivata OneSign, Imprivata Confirm ID provides European healthcare organizations with a comprehensive authentication platform that boosts clinical
Here is a recap of the most popular biometrics industry news that appeared on BiometricUpdate.com this past week. Healthcare Intent Solutions has introduced new medical device technology called TAD, “Take As Directed”. TAD is built around a portable dispenser containing a disposable vial filled with medication attached to a reusable electronic device. The device is designed to be pre-programmed with the prescribed regimen and patient biometrics. The device notifies the patient that it’s time to take the pill, scans their